• Technology and Data
  • Front End Sales and Marketing
  • Allergy
  • HIV
  • Women's Health
  • Migraine
  • Compounding
  • Continuous Glucose Monitoring
  • Mental Health Awareness
  • Veterinary Pharmacy
  • CBD
  • Infectious Disease
  • Eye Health
  • Digestive Health
  • Biosimilars
  • Influenza
  • Shingles
  • COPD Management
  • Pediatrics
  • Generics
  • Pain Management
  • COVID-19
  • Immunization
  • Oncology
  • Anticoagulants
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Respiratory
  • Heart Health
  • Cardiovascular Clinical Consult

Mix-up leads to nationwide azathioprine recall

Article

A lot of azathioprine 50-mg tablets (Lot 558470A, Exp. March 2009) has been recalled by Roxane Laboratories after the company discovered a single bottle containing methotrexate 2.5-mg tablets.

Mix-up leads to nationwide azathioprine recall

A lot of azathioprine 50-mg tablets (Lot 558470A, Exp. March 2009) has been recalled by Roxane Laboratories after the company discovered a single bottle containing methotrexate 2.5-mg tablets. Information has been sent to pharmacists alerting them to the error and urging them to contact those patients who may have filled azathioprine prescriptions with tablets from the recalled lot. Pharmacists and wholesalers that have any bottles of the affected lot should discontinue distribution immediately and contact Capital Returns at 1-(800) 950-5479 (menu option 1).

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.